ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,459, issued on June 2, was assigned to D.T.R. Dermal Therapy Research Inc. (London, Canada).
"Implantable glucose sensor" was invented by Stig Ollmar (Huddinge, Sweden), Saul Alejandro Rodriguez Duenas (Jarfalla, Sweden), Ana Rusu (Sollentuna, Sweden), Ulrik Birgersson (Stockholm) and Alejandro Fernandez Schrunder (Stockholm).
According to the abstract* released by the U.S. Patent & Trademark Office: "An implantable glucose sensor includes: a housing, two injecting electrodes for injecting current into the tissue, two sensing electrodes for measuring impedance in the tissue, a coil within the housing for powering the sensor via a power source, a circuit board within the housing, t...